Circulatory System Drugs

[6-(Methylcarbamoyloxymethyl)Pyridin-2-yl]Methyl N-Methylcarbamate; Pyridine-2,6-Diyldi(Methylene)-bis(Methylcarbamate); Pyridinol Carbamate; Parmidine; Anginin; Atover; Duaxol; Movecil

Guanabenz Acetate;; Wytensin;; WY-8678 Acetate;; Guanabenz (Acetate);; Guanabenz Acetate Salt; ((2,6-Dichlorobenzylidene)Amino)-Guanidinmonoacetate; 2-((2,6-Dichlorophenyl)Methylene)-Hydrazinecarboximidamidmonoacetate; [2,6-Dichlorobenzylidene)-Amino]Guanidine; [(2,6-Dichlorobenzylidene)Amino]Guanidine Acetate

Complamin; Contamex; Icotinicacid; Methoxylin,Compd.Withnicotinicacid; Nicotinicacid,Compd.With3,7-Dihydro-7-(2-Hydroxy-3-((2-Hydroxyethyl)Methyl; Sadamin; Stenalgil; Teonicol; 7-[2-Hydroxy-3-[2-Hydroxyethyl(Methyl)Amino]Propyl]-1,3-Dimethylpurine-2,6-Dione,Pyridine-3-Carboxylic acid; Xantinol Nicotinate; Xanthinol Niacinate; Angioamin; Complamex; Xanthinolnicotinat; Sadamine; Landrina

Flecainide (Acetate); Tambocor; R-818; Flecainide Monoacetate; Flecainide Acetate salt; N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-Trifluoroethoxy)Benzamide Acetate; N-(Piperidin-2-Ylmethyl)-2,5-bis(2,2,2-Trifluoroethoxy)Benzamide Monoacetate; Apocard; Benzamide, N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-Trifluoroethoxy)-, Monoacetate; Benzamide, N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-Trifluoroethoxy)-,Monoacetate; N-(2-Piperidylmethyl)-2,5-bis(2,2,2-Trifluoroethoxy)Benzamide Monoacetate; Acetic acid;N-(Piperidin-2-Ylmethyl)-2,5-bis(2,2,2-Trifluoroethoxy)Benzamide; n-(Piperidin-2-Ylmethyl)-2,5-bis(2,2,2-Trifluoroethoxy)Benzamide Acetate; Flecainidacetat; N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-Trifluoroethoxy)Benzamide Monoacetate; 2,5-Bis-(2,2,2-Trifluoroethoxy)-N-(2-Piperidinylmethyl)Benzamide Acetate; Flecainide for System Suitability; 11A-Hydroxyepoxyprogesterone; N-(Piperidin-2-Ylmethyl)-2,5-bis[(2,2,2-Trifluoroethyl)oxy]Benzamide Acetate; Flecainide Acetate, British Pharmacopoeia (BP) Reference Standard; Flecainide Acetate, European Pharmacopoeia (EP) Reference Standard; 2,5-bis(2,2,2-Trifluoroethoxy)-N-(2-Piperidylmethyl)Benzamide Acetate; Flecainide Acetate, United States Pharmacopeia (USP) Reference Standard; 2-({[2,5-bis(2,2,2-Trifluoroethoxy)Benzoyl]Amino}Methyl)Piperidinium Acetate; Flecainide for System Suitability, European Pharmacopoeia (EP) Reference Standard

(2S)-1-[(2S)-6-Amino-2-[[(1S)-1-Carboxy-3-Phenylpropyl]Amino]-1-Oxohexyl]-2-Pyrrolidinecarboxylic acid;Hydrate; (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-Carboxy-3-Phenyl-Propyl]Amino]Hexanoyl]Proline;Hydrate; (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-Carboxy-3-Phenylpropyl]Amino]Hexanoyl]Pyrrolidine-2-Carboxylic acid; (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-Carboxy-3-Phenylpropyl]Amino]Hexanoyl]Pyrrolidine-2-Carboxylic acid;Hydrate; (2S)-1-[(2S)-6-Amino-2-[[(1S)-1-Carboxy-3-Phenyl-Propyl]Amino]Hexanoyl]Pyrrolidine-2-Carboxylic acid;Lisinopril; (2S)-1-[(2S)-6-Amino-2-[[(2S)-1-Hydroxy-1-oxo-4-Phenylbutan-2-yl]Amino]Hexanoyl]Pyrrolidine-2-Carboxylic acid; (2S)-1-[(2S)-6-Amino-2-{[(1S)-1-Carboxy-3-Phenylpropyl]Amino}Hexanoyl]-2-Pyrrolidinecarboxylic acid; (2S)-1-[(2S)-6-Amino-2-{[(1S)-1-Carboxy-3-Phenylpropyl]Amino}Hexanoyl]Pyrrolidine-2-Carboxylic acid; (2S)-1-[(2S)-6-Azanyl-2-[[(2S)-1-Oxidanyl-1-Oxidanylidene-4-Phenyl-Butan-2-yl]Amino]Hexanoyl]Pyrrolidine-2-Carboxylic acid;Hydrate; (S)-1-((S)-6-Amino-2-(((S)-1-Carboxy-3-Phenylpropyl)Amino)Hexanoyl)Pyrrolidine-2-Carboxylic acid; (S)-1-((S)-6-Amino-2-((S)-1-Carboxy-3-Phenylpropylamino)Hexanoyl)Pyrrolidine-2-Carboxylic acid; (S)-1-(N(2)-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-L-Proline; (S)-1-(N(sup 2)-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-L-Proline; (S)-1-(N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-L-Proline; (S)-1-[(S)-6-Amino-2-((S)-1-Carboxy-3-Phenyl-Propylamino)-Hexanoyl]-Pyrrolidine-2-Carboxylic ACID; (S)-1-[N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl]-L-Proline; (S)-1-[N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl]-L-Proline Dihydrate; (S)-1-[N2-(1-Carboxy-3-Phenylpropyl)-Lysyl-Proline Dihydrate; (S)-Lisinopril Dihydrate; [N2-[(S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-L-Proline; 1-(N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-L-Proline; 1-[Nalpha-[(S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl]-L-Proline; 1-{N-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl}-L-Prolin; Acerbon; Acercomp; Alapril; Amicor; Carace; Cipral; Coric; Diroton; Doneka; Hipril; Inhibril; Inopril; Irumed; Laaven; Linopril; Linvas; Lipril; Lisinal; Lisinopril Anhydrous; Lisinoprilum; Lisipril; Lisiprilprinivil; Lisitec; Lisopril; Lisoril; Lispril; Listril; Lizinopril; Lizonoton; Longes; Loril; LPR; L-Proline, 1-(N(sup 2)-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-, (S)-; L-Proline, 1-(N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-; L-Proline, 1-(N2-(1-Carboxy-3-Phenylpropyl)-L-Lysyl)-, (S)-; L-Proline, N-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-; L-Proline, N2-((1S)-1-Carboxy-3-Phenylpropyl)-L-Lysyl-; Lysinopril; Lysinopryl; mk522; N-(1(S)-Carboxy-3-Phenylpropyl)-L-Lysyl-L-Proline; N(2)-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-L-Proline; N-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-L-Prolinato; N-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-L-Proline; N-[N2 (1(S)-Carboxy-3-Phenylpropyl)-L-Lysyl]-L-Proline; N-[N2 -(1(S)-Carboxy-3-Phenylpropyl)-L-Lysyl]-L-Proline; n-{n-[(s)-1-Carboxy-3-Phenylpropyl]-l-Lysyl}-l-Proline; N2-((S)-1-Carboxy-3-Phenylpropyl)-L-Lysyl-L-Proline; N2-[(1S)-1-Carboxy-3-Phenylpropyl]-L-Lysyl-L-Proline; Nanopril; Noperten; Novatec; Optimon; Presiten; Prinil; Prinivil; Prinvil; Qbrelis; Renacor; Sinopril; Sinopryl; Skopryl; Tensopril; Tensyn; Tersif; Vitopril; Vivatec; Zestril